massively parallel sequencing
Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study
The study will offer whole-genome sequencing and genetic risk scores for type 1 diabetes for newborns born in North Carolina.
Business in China is not going as well as expected for many US companies, especially those selling sequencing- and mass spec-related research tools.
Bigger isn't always better, as Singular Genomics, MGI Tech, and now Element build out product lines for smaller-scale sequencing. But are they going small enough?
Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays
The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.
Francis deSouza's sudden departure over his signature Grail deal leaves analysts and customers wondering what's next for Illumina.